Greek swimmer Kristian Gkolomeev won the men's 50-metre freestyle at the first Enhanced Games in Las Vegas on Sunday [1], [2].

The event marks a departure from traditional athletics by allowing competitors to use performance-enhancing drugs legally. This shift creates a new competitive environment where the limits of human performance are tested without the restrictions of standard anti-doping regulations.

Gkolomeev clocked a time of 20.81 seconds [2]. While this mark is described as a world-record time, it is not officially recognized by traditional governing bodies [2]. For his victory, Gkolomeev earned a cash prize reported by some sources as $1.75 million [1], though other reports place the figure at $1 million [3] or $350,000 [1].

The competition took place at Resorts World Las Vegas, Nevada [2], [3]. The final day of the games concluded on May 24, 2026 [3].

Not all athletes found success in the chemically enhanced environment. Australian swimmer James Magnussen finished last in both of his events [1]. Magnussen had reportedly used significant amounts of performance-enhancing substances in an attempt to chase a world record [1].

After finishing last in his two events, having "juiced to the gills" to chase a world record, James Magnussen said his fellow Enhanced Games competitors were "not talking about Cam" [1].

The disparity in results between Gkolomeev and Magnussen highlights the unpredictable nature of performance-enhancing regimens. Despite the availability of banned substances, the outcome of the races remained dependent on individual athlete response, and training.

“Kristian Gkolomeev clocked a time of 20.81 seconds.”

The inaugural Enhanced Games challenge the fundamental premise of the Olympic movement by decoupling athletic competition from drug-free mandates. By offering multimillion-dollar prizes and removing doping bans, the event creates a separate tier of professional sports that prioritizes absolute physical output over the concept of 'clean' sport, potentially shifting how elite athletes view pharmacological assistance.